The emerging approach of this peptide represents a exciting advance in the care of diabetes mellitus type 2. Unlike existing therapies, tirzepatide targets two pathways – glucagon-like peptide-1 (GLP-1) and GIP – https://tirzepatide-peptide942476.blogolize.com/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment-81216440